Surgery Websites
Vascular & Endovascular Surgery »  Education & Training »  Clinical Fellows »  Vascular Surgery »  Past Fellows »  Peter A. Schneider, M.D.
Peter A. Schneider, M.D.

Peter A. Schneider, M.D.

  • Professor of Surgery
  • Division of Vascular and Endovascular Surgery

Contact Information

Division of Vascular and Endovascular Surgery
400 Parnassus Avenue, A-501
San Francisco, CA 94143-0957
Phone: (415) 353-2357
Fax: (415) 353-2669
[email protected]
Open Popup

The Johns Hopkins University School of Medicine Five-Year BA-MD Curriculum, The Johns Hopkins University, Baltimore, MD, Class of 1983

Undergraduate, University of California San Diego, La Jolla, CA, 1976-1978

  • University of California San Francisco, San Francisco, CA
  • Resident in General Surgery, June, 1983 to June, 1986 and July, 1988 to June, 1989
  • Chief Resident in General Surgery, July, 1989 to June, 1990
  • Research Fellowship: Roon Center of Arteriosclerosis and Thrombosis, Department of Basic Research and Noninvasive Vascular Diagnostic Laboratory, Scripps Clinic and Research Foundation, La Jolla, CA, July, 1986 to June, 1988
  • Clinical Fellowship: University of California San Francisco, San Francisco, CA, Clinical Fellow in Vascular Surgery, July, 1990 to June, 1991
  • American Board of Surgery, Vascular Surgery

Peter A. Schneider, M.D. is Professor of Surgery in the Division of Vascular & Endovascular Surgery at University of California San Francisco. Dr. Schneider received his MD from the Johns Hopkins School of Medicine and completed his general surgery residency and vascular surgery fellowship at the University of California San Francisco.

Dr. Schneider was the founding member and chief of the Division of Vascular Surgery at Kaiser Permanente in Hawaii from 1994-2018. At Kaiser, he helped to develop a Diabetic Limb Treatment Program and a surveillance program for patients with aneurysms and a registry for patients with carotid disease used for surveillance. He oversaw the development of the first endovascular operating room in the Kaiser system.

Dr. Schneider has served on numerous committees for the Society for Vascular Surgery and is the past president of Western Vascular Society where he also served on a number of its committees. He has been invited to numerous visiting professorships and has served as faculty or course director for many specialty courses. He authored "Endovascular Skills," the 4th edition, to be published in 2019, and has co-authored three other books on various aspects of vascular surgery. Dr. Schneider founded two medical device companies, served as an adviser to many others, and has been awarded numerous patents.

Dr. Schneider is a Distinguished Fellow of the Society for Vascular Surgery.

Dr. Schneider has served as National Principal Investigator for numerous clinical trials. Over 25 years, he has been a strong proponent of clinical research in vascular disease and has participated extensively in trial design, oversight, core lab analysis, events committees, data analysis, follow up, presentation, and publication. He has consulted on the regulatory pathway and pivotal trials for many vascular devices, has participated in numerous meetings with the FDA and has testified at FDA panel hearings. His experience includes performing procedures for several first-in-human trials. 

Data provided by UCSF Profiles, powered by CTSI
  1. Paraskevas KI, Brown MM, Lal BK, Myrcha P, Lyden SP, Schneider PA, Poredos P, Mikhailidis DP, Secemsky EA, Musialek P, Mansilha A, Parikh SA, Silvestrini M, Lavie CJ, Dardik A, Blecha M, Liapis CD, Zeebregts CJ, Nederkoorn PJ, Poredos P, Gurevich V, Jawien A, Lanza G, Gray WA, Gupta A, Svetlikov AV, Fernandes E Fernandes J, Nicolaides AN, White CJ, Meschia JF, Cronenwett JL, Schermerhorn ML, AbuRahma AF. Recent Advances and Controversial Issues in the Optimal Management of Asymptomatic Carotid Stenosis. J Vasc Surg. 2023 Nov 06. View in PubMed
  2. Parikh SA, Schneider PA, Mullin CM, Rogers T, Gray WA. Mortality in randomised controlled trials using paclitaxel-coated devices for femoropopliteal interventional procedures: an updated patient-level meta-analysis. Lancet. 2023 Oct 23. View in PubMed
  3. Schneider PA. The conundrum of below the knee (BTK) drug delivery. Vasc Med. 2023 Oct 16; 1358863X231204626. View in PubMed
  4. Smith JA, Chung JM, Schneider PA, Kwolek CJ, Arko FR, Henao S, Titus J, DiMuzio P, Roddy S, Farber MA, Kashyap VS, ROADSTER Trial Investigators. Female and male patients have similar outcomes after transcarotid artery revascularization in prospective trials. J Vasc Surg. 2023 Sep 15. View in PubMed
  5. Rundback J, Kawai K, Sato Y, Brodmann M, Schneider P, Corbet MB, Kawakami R, Konishi T, Ghosh SKB, Virmani R, Finn AV. Treatment effect of medial arterial calcification in below-knee after Auryon laser atherectomy using micro-CT and histologic evaluation. Cardiovasc Revasc Med. 2023 Jun 28. View in PubMed
  6. View All Publications


Site Directory